BioNote, Inc. (KRX:377740)
South Korea
· Delayed Price · Currency is KRW 5,630.00
+40.00 (0.72%)
Last updated: Dec 5, 2025, 2:19 PM KST
BioNote Revenue
BioNote had revenue of 29.50B KRW in the quarter ending September 30, 2025, with 11.53% growth. This brings the company's revenue in the last twelve months to 115.09B, up 15.32% year-over-year. In the year 2024, BioNote had annual revenue of 102.78B with 14.10% growth.
Revenue (ttm)
115.09B
Revenue Growth
+15.32%
P/S Ratio
4.97
Revenue / Employee
386.22M
Employees
298
Market Cap
571.68B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |